These effects were validated on tumor control in a melanoma tumor cell-inoculated model (78) and indicated that GABARAP in non-cancerous cells is sufficient to sustain pro-tumorigenic effects potentially due to control of cytokine secretion. This evidence concerns the gene GABARAP and neoplasm.